Table 1 Clinical characteristics of kidney transplant patients, (n = 450)
Characteristics | N (%) |
|---|---|
Age at transplantation (years) | 45 ± 13 |
<60 | 377 (83.8) |
≥ 60 | 73 (16.2) |
Gender | |
Male | 293 (65.1) |
Female | 157 (34.9 |
Follow up time (months); median (range) | 38 (2-71) |
Type of donor | |
Live related donor | 192 (42.7) |
Diseased donor | 258 (57.3) |
Number of transplant | |
First | 436 (96.9) |
Second | 11 (2.4) |
Third | 3 (0.7) |
Induction agent | |
Daclizumab | 237 (52.7) |
Basiliximab | 176 (39.1) |
Anti-thymocyte globulin | 23 (5.1) |
None | 14 (3.1) |
Death at last follow-up | |
No | 439 (97.6) |
Yes | 11 (2.4) |
Graft functionality at death | |
Unknown | 1 (9.1) |
Graft in function | 8 (72.7) |
Graft not in function | 2 (18.2) |
Rejection | |
No | 417 (92.6) |
Yes | 33 (7.4) |
Pre-transplant VZV disease | |
No | 51 (11.3) |
Yes | 201 (44.7) |
Unknown | 198 (44) |